EFM

E Fund Management Portfolio holdings

AUM $2.1B
1-Year Est. Return 23.31%
This Quarter Est. Return
1 Year Est. Return
+23.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.09B
AUM Growth
+$101M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
437
New
Increased
Reduced
Closed

Top Buys

1 +$22.7M
2 +$17M
3 +$15.1M
4
AMZN icon
Amazon
AMZN
+$13.7M
5
META icon
Meta Platforms (Facebook)
META
+$13.3M

Top Sells

1 +$95M
2 +$15.8M
3 +$10.2M
4
TME icon
Tencent Music
TME
+$10M
5
TSM icon
TSMC
TSM
+$8.26M

Sector Composition

1 Technology 37.79%
2 Consumer Discretionary 26.64%
3 Communication Services 10.64%
4 Healthcare 6.89%
5 Financials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBL icon
301
Jabil
JBL
$21.6B
$315K 0.02%
2,318
HSIC icon
302
Henry Schein
HSIC
$7.76B
$315K 0.02%
4,596
-56
FFIV icon
303
F5
FFIV
$17.2B
$314K 0.02%
1,180
ACAD icon
304
Acadia Pharmaceuticals
ACAD
$3.55B
$311K 0.01%
18,718
+8,090
ALGN icon
305
Align Technology
ALGN
$9.86B
$310K 0.01%
1,954
+421
SLNO icon
306
Soleno Therapeutics
SLNO
$3.47B
$310K 0.01%
4,332
-371
TECH icon
307
Bio-Techne
TECH
$9.99B
$309K 0.01%
5,262
+621
MMC icon
308
Marsh & McLennan
MMC
$92.9B
$308K 0.01%
1,263
+47
VCYT icon
309
Veracyte
VCYT
$2.87B
$308K 0.01%
10,371
+3,979
DE icon
310
Deere & Co
DE
$125B
$307K 0.01%
654
+24
CMCM
311
Cheetah Mobile
CMCM
$230M
$305K 0.01%
+71,363
VTRS icon
312
Viatris
VTRS
$12.1B
$302K 0.01%
34,703
+6,156
RARE icon
313
Ultragenyx Pharmaceutical
RARE
$3.3B
$301K 0.01%
8,300
+1,100
ZBRA icon
314
Zebra Technologies
ZBRA
$15.6B
$300K 0.01%
1,061
DUK icon
315
Duke Energy
DUK
$99.5B
$299K 0.01%
2,450
+577
ETN icon
316
Eaton
ETN
$146B
$297K 0.01%
1,091
+33
RXRX icon
317
Recursion Pharmaceuticals
RXRX
$2.68B
$296K 0.01%
55,925
+13,604
GEN icon
318
Gen Digital
GEN
$16.6B
$292K 0.01%
11,008
CB icon
319
Chubb
CB
$107B
$291K 0.01%
964
+36
TER icon
320
Teradyne
TER
$22.6B
$290K 0.01%
3,505
-20,125
RYTM icon
321
Rhythm Pharmaceuticals
RYTM
$7.11B
$286K 0.01%
+5,396
WDC icon
322
Western Digital
WDC
$41.4B
$283K 0.01%
7,012
-2,265
AKRO icon
323
Akero Therapeutics
AKRO
$4.32B
$280K 0.01%
+6,924
CRL icon
324
Charles River Laboratories
CRL
$9.26B
$279K 0.01%
1,853
+33
AJG icon
325
Arthur J. Gallagher & Co
AJG
$71.5B
$277K 0.01%
+803